Propanc Biopharma Publishes Evaluation of Recombinant Trypsinogen & Chymotrypsinogen in Peer Reviewed Journal

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/18/2026

1. XENE
2. SPY
3. HUBS
4. NUE
5. ONON
6. AAPL
7. TRMD
8. AZN
9. NVDA
10. USO

Go back to Propanc Biopharma Publishes Evaluation of Recombinant Trypsinogen & Chymotrypsinogen in Peer Reviewed Journal
(NASDAQ: PPCB) Delayed: 0.65 +0.02 (3.17%)
Previous Close $0.63    52 Week High $ 
Open $0.66    52 Week Low $ 
Day High $0.67    P/E N/A 
Day Low $0.63    EPS $ 
Volume 59,591       

(NASDAQ: PPCB) Delayed: 0.65 +0.02 (3.17%)
Previous Close $0.63    52 Week High $ 
Open $0.66    52 Week Low $ 
Day High $0.67    P/E N/A 
Day Low $0.63    EPS $ 
Volume 59,591